CC
COGT icon

Corton Capital’s Cogent Biosciences COGT Stock Holding History

Corton Capital’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,438
Closed -$125K – 238
2025
Q2 		$125K Buy
17,438
+1,046
+6% +$5.8K 0.15% 296
2025
Q1 		$98.2K Sell
16,392
-12,369
-43% -$97K 0.32% 130
2024
Q4 		$224K Buy
+28,761
New +$287K 0.13% 224
2024
Q3 		– Sell
-12,162
Closed -$103K – 519
2024
Q2 		$103K Buy
+12,162
New +$92.2K 0.05% 453

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Corton Capital's COGT Position: Q3 2025 in Review

Corton Capital sold out of Cogent Biosciences (COGT) in Q3 2025, closing a stake of 17,438 shares — an estimated $125K sold.

Corton Capital first reported a position in COGT in Q2 2024 and held it in 4 quarters. The position peaked at $224K in Q4 2024. 195 funds tracked by Wall St. Rank hold COGT as of Q3 2025.

  • Corton Capital reported no remaining Cogent Biosciences position as of Q3 2025 after selling out during the quarter.
  • Corton Capital sold 17,438 Cogent Biosciences shares in Q3 2025, an estimated $125K.
  • Corton Capital first reported a position in Cogent Biosciences in Q2 2024 and held it in 4 quarters.
  • Corton Capital's Cogent Biosciences position peaked at $224K in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.